The federal charges against Indivior accused the company of raking in billions of dollars from Suboxone Film prescriptions by deceiving health care providers and health care benefit programs into believing the film, which contains a powerful opioid, was safer and "less abusable" than other opioid addiction treatment drugs, the Justice Department said in a news release last year.